Controlled trial of prescribed heroin in the treatment of opioid addiction

Journal of Substance Abuse Treatment

Volumn 31, Issue 2, 2006, Pages 203-211

  March, Joan Carles ^a   Oviedo Joekes, Eugenia ^a   Perea Milla, Emilio ^b   Carrasco, Francisco ^c  

^a ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^b HOSPITAL COSTA DEL SOL   (Spain)

^c Andalusian Health Care Service   (Spain)

Author keywords

Diacetylmorphine; Drug users; intravenous; Methadone; Opiate dependence; Social exclusion; therapeutic use

Indexed keywords

DIAMORPHINE; METHADONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DEPENDENCE TREATMENT; DRUG EFFICACY; DRUG FATALITY; DRUG OVERDOSE; FAMILY; FEMALE; HEALTH STATUS; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTEGRATION; INTOXICATION; MALE; MENTAL HEALTH; METHADONE TREATMENT; OPIATE ADDICTION; PHASE 3 CLINICAL TRIAL; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SOCIAL STATUS; SPAIN;

ADULT; COUNSELING; DRUG ADMINISTRATION SCHEDULE; DRUG PRESCRIPTIONS; FEMALE; HEALTH STATUS; HEPATITIS B; HEPATITIS C; HEROIN; HIV SEROPOSITIVITY; HUMANS; MALE; METHADONE; NARCOTICS; OPIOID-RELATED DISORDERS; PRESCRIPTIONS, DRUG; RISK-TAKING; SEVERITY OF ILLNESS INDEX; SOCIAL SUPPORT;

EID: 33747116923     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2006.04.007     Document Type: Article

References (29)

1. Altman D.G., and Bland J.M. How to randomise. British Medical Journal 319 (1999) 703-704
2. Blattler R., Dobler-Mikola A., Steffen T., and Uchtenhagen A. Decreasing intravenous cocaine use in opiate users treated with prescribed heroin. Sozial- und Präventivmedizin 47 (2002) 24-32
3. Brehmer C., and Iten P.X. Medical prescription of heroin to chronic heroin addicts in Switzerland-A review. Forensic Science International 121 (2001) 23-26
4. Drug Commissioned. (2002). II Plan Andaluz sobre Drogas y Adicciones. [Report 2002]. Sevilla. Junta de Andalucía. Consejería para la Igualdad y Bienestar Social.
5. Drug Commissioned. (2005). Evidence based clinical guidelines for opioid dependence treatment. Sevilla. Junta de Andalucía. Consejería para la Igualdad y Bienestar Social.
6. Darke S., Hall W., Wodak A., Heather N., and Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: The Opiate Treatment Index. British Journal of Addiction 87 (1992) 733-742
7. Derogatis L.R., and Cleary P.A. Factorial invariance across gender for the primary symptom dimensions of the SCL-90. British Journal of Social and Clinical Psychology 16 (1977) 347-356
8. Dijkgraaf M.G., van der Zanden B.P., de Borgie C.A., Blanken P., van Ree J.M., and van den Brink W. Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomized trials. British Medical Journal 330 (2005) 1297
9. Domingo-Salvany A. Methadone maintenance treatment in Spain. Analysis of active centers in 1997. Paper Presented at VI Encuentro Nacional Sobre Drogodependencias y su Enfoque Comunitario, Chiclana de la Frontera (Cadiz), Spain (1997)
10. EMCDDA. Reviewing current practice in drug-substitution treatment in the European Union (2000), Office for Official Publications of the European Communities, Luxemburg
11. Farrell M., Ward J., Mattick R., Hall W., Stimson G.V., des Jarlais D., et al. Methadone maintenance treatment in opiate dependence: A review. British Medical Journal 309 (1994) 997-1001
12. Ferri M., Davoli M., and Perucci C.A. Heroin maintenance for chronic heroin dependents. Cochrane Database System Review (2005) CD003410
13. Fischer B., Rehm J., Kirst M., Casas M., Hall W., Krausz M., et al. Heroin-assisted treatment as a response to the public health problem of opiate dependence. European Journal of Public Health 12 (2002) 228-234
14. Gandek B., Ware J.E., Aaronson N.K., Apolone G., Bjorner J.B., Brazier J.E., et al. Cross-validation of item selection and scoring for the SF-12 health survey in nine countries: Results from the IQOLA project. International Quality of Life Assessment. Journal of Clinical Epidemiology 51 (1998) 1171-1178
15. Hartnoll R.L., Mitcheson M.C., Battersby A., Brown G., Ellis M., Fleming P., et al. Evaluation of heroin maintenance in controlled trial. Archives of General Psychiatry 37 (1980) 877-884
16. March J.C., Oviedo-Joekes E., and Romero M. Drugs and social exclusion in ten European cities. European Addiction Research 12 (2006) 33-41
17. March J.C., Oviedo-Joekes E., Romero M., and Sánchez-Cantalejo E. Intravenous and inhalable route of heroin administration related factors among street users. Revista Española de Salud Pública 79 (2005) 391-401
18. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., and Grissom G. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 9 (1992) 199-213
19. OFSP. Manuel Traitement avec prescription d'héroine. Directives, recommandations, informations (2001), Office Fédéral de la Santé Publique, Berne, Switzerland
20. Perez de Los Cobos J., Trujols J., Valderrama J.C., Valero S., and Puig T. Patient perspectives on methadone maintenance treatment in the Valencia Region: Dose adjustment, participation in dosage regulation, and satisfaction with treatment. Drug and Alcohol Dependence 79 (2005) 405-412
21. Perneger T.V., Giner F., del Rio M., and Mino A. Randomized trial of heroin maintenance program for addicts who fail in conventional drug treatments. British Medical Journal 317 (1998) 13-18
22. Perneger T.V., Mino A., Giner F., and Broers B. Patterns of opiate use in a heroin maintenance program. Psychopharmacology (Berl) 152 (2000) 7-13
23. Rehm J., Gschwend P., Steffen T., Gutzwiller F., Dobler-Mikola A., and Uchtenhagen A. Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: A follow-up study. Lancet 358 (2001) 1417-1423
24. SPSS. SPSS 12.0.1 for Windows (2003), Chicago
25. Steffen T., Christen S., Blattler R., and Gutzwiller F. Infectious diseases and public health: Risk-taking behavior during participation in the Swiss program for a medical prescription of narcotics (PROVE). Substance Use and Misuse 36 (2001) 71-89
26. Torrens M., San L., Martinez A., Castillo C., Domingo-Salvany A., and Alonso J. Use of the Nottingham health profile for measuring health status of patients in methadone maintenance treatment. Addiction 92 (1997) 707-716
27. Uchtenhagen A., Dobler-Mikola A., Steffen T., Gutzwiller F., Bläter R., and Pfeifer S. Prescription of narcotics for heroin addicts: Main results of the Swiss national cohort study (1999), Karger, New York
28. van den Brink W., Hendriks V.M., Blanken P., Koeter M.W., van Zwieten B.J., and van Ree J.M. Medical prescription of heroin to treatment resistant heroin addicts: Two randomized controlled trials. British Medical Journal 327 (2003) 310
29. Ward J., Hall W., and Mattick R.P. Role of maintenance treatment in opioid dependence. Lancet 353 (1999) 221-226